Td Asset Management Inc Exact Sciences Corp Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

A detailed history of Td Asset Management Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Td Asset Management Inc holds 477,756 shares of EXAS stock, worth $28.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
477,756
Previous 362,974 31.62%
Holding current value
$28.4 Million
Previous $15.3 Million 112.13%
% of portfolio
0.03%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$42.43 - $70.83 $4.87 Million - $8.13 Million
114,782 Added 31.62%
477,756 $32.5 Million
Q2 2024

Aug 02, 2024
SELL
$41.33 - $74.26 $691,781 - $1.24 Million
-16,738 Reduced 4.41%
362,974 $15.3 Million
Q1 2024

May 08, 2024
SELL
$56.27 - $73.77 $309,653 - $405,956
-5,503 Reduced 1.43%
379,712 $26.2 Million
Q4 2023

Feb 12, 2024
SELL
$59.06 - $75.72 $2.05 Million - $2.62 Million
-34,655 Reduced 8.25%
385,215 $28.5 Million
Q3 2023

Oct 27, 2023
BUY
$65.94 - $99.04 $4.55 Million - $6.84 Million
69,071 Added 19.69%
419,870 $28.6 Million
Q2 2023

Aug 09, 2023
BUY
$62.68 - $95.05 $1.66 Million - $2.51 Million
26,432 Added 8.15%
350,799 $32.9 Million
Q1 2023

May 10, 2023
BUY
$47.19 - $70.77 $464,019 - $695,881
9,833 Added 3.13%
324,367 $22 Million
Q4 2022

Feb 06, 2023
SELL
$30.35 - $53.15 $908,132 - $1.59 Million
-29,922 Reduced 8.69%
314,534 $15.6 Million
Q3 2022

Nov 07, 2022
SELL
$31.97 - $49.37 $443,423 - $684,761
-13,870 Reduced 3.87%
344,456 $11.4 Million
Q2 2022

Aug 04, 2022
SELL
$35.61 - $76.23 $400,754 - $857,892
-11,254 Reduced 3.05%
358,326 $14.1 Million
Q1 2022

May 10, 2022
SELL
$57.56 - $82.54 $773,261 - $1.11 Million
-13,434 Reduced 3.51%
369,580 $25.8 Million
Q4 2021

Feb 10, 2022
BUY
$72.5 - $100.68 $7.49 Million - $10.4 Million
103,367 Added 36.96%
383,014 $29.8 Million
Q3 2021

Nov 09, 2021
SELL
$90.24 - $124.05 $127,328 - $175,034
-1,411 Reduced 0.5%
279,647 $26.7 Million
Q2 2021

Aug 11, 2021
BUY
$93.66 - $139.27 $2.02 Million - $3.01 Million
21,597 Added 8.32%
281,058 $30.3 Million
Q1 2021

May 14, 2021
BUY
$116.57 - $155.01 $1.83 Million - $2.43 Million
15,681 Added 6.43%
259,461 $34.2 Million
Q4 2020

Feb 16, 2021
SELL
$99.61 - $142.12 $10 Million - $14.3 Million
-100,870 Reduced 29.27%
243,780 $32.3 Million
Q3 2020

Nov 10, 2020
BUY
$72.92 - $102.01 $1.75 Million - $2.45 Million
24,002 Added 7.49%
344,650 $35.1 Million
Q2 2020

Aug 13, 2020
BUY
$55.75 - $92.75 $689,794 - $1.15 Million
12,373 Added 4.01%
320,648 $27.9 Million
Q1 2020

May 15, 2020
BUY
$37.9 - $104.44 $2.63 Million - $7.24 Million
69,335 Added 29.02%
308,275 $17.9 Million
Q4 2019

Feb 11, 2020
BUY
$77.66 - $99.74 $7.89 Million - $10.1 Million
101,644 Added 74.03%
238,940 $22.1 Million
Q3 2019

Nov 07, 2019
BUY
$90.37 - $122.49 $1.09 Million - $1.48 Million
12,106 Added 9.67%
137,296 $12.4 Million
Q2 2019

Aug 01, 2019
BUY
$89.51 - $118.04 $267,634 - $352,939
2,990 Added 2.45%
125,190 $14.8 Million
Q1 2019

May 08, 2019
SELL
$61.98 - $96.5 $588,810 - $916,750
-9,500 Reduced 7.21%
122,200 $10.6 Million
Q4 2018

Feb 01, 2019
SELL
$56.04 - $82.66 $594,024 - $876,196
-10,600 Reduced 7.45%
131,700 $8.31 Million
Q3 2018

Nov 01, 2018
BUY
$48.29 - $80.6 $4.09 Million - $6.83 Million
84,700 Added 147.05%
142,300 $11.2 Million
Q2 2018

Jul 31, 2018
BUY
$37.84 - $69.96 $2.18 Million - $4.03 Million
57,600 New
57,600 $3.44 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email